DexCom Price to Book Ratio 2010-2024 | DXCM
Historical price to book ratio values for DexCom (DXCM) over the last 10 years. The current price to book ratio for DexCom as of May 01, 2025 is 13.05.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| DexCom Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-01 | 70.26 | 13.06 | |
| 2024-12-31 | 77.77 | $5.38 | 14.45 |
| 2024-09-30 | 67.04 | $5.07 | 13.23 |
| 2024-06-30 | 113.38 | $6.08 | 18.66 |
| 2024-03-31 | 138.70 | $5.67 | 24.45 |
| 2023-12-31 | 124.09 | $5.37 | 23.12 |
| 2023-09-30 | 93.30 | $5.87 | 15.90 |
| 2023-06-30 | 128.51 | $5.44 | 23.62 |
| 2023-03-31 | 116.18 | $5.76 | 20.17 |
| 2022-12-31 | 113.24 | $5.52 | 20.52 |
| 2022-09-30 | 80.54 | $4.72 | 17.05 |
| 2022-06-30 | 74.53 | $5.75 | 12.97 |
| 2022-03-31 | 127.90 | $5.58 | 22.92 |
| 2021-12-31 | 134.24 | $5.26 | 25.51 |
| 2021-09-30 | 136.72 | $5.51 | 24.81 |
| 2021-06-30 | 106.75 | $5.16 | 20.67 |
| 2021-03-31 | 89.85 | $4.92 | 18.26 |
| 2020-12-31 | 92.43 | $4.75 | 19.45 |
| 2020-09-30 | 103.06 | $3.90 | 26.40 |
| 2020-06-30 | 101.35 | $3.55 | 28.57 |
| 2020-03-31 | 67.32 | $2.53 | 26.60 |
| 2019-12-31 | 54.69 | $2.41 | 22.70 |
| 2019-09-30 | 37.31 | $2.09 | 17.87 |
| 2019-06-30 | 37.46 | $1.89 | 19.85 |
| 2019-03-31 | 29.78 | $1.84 | 16.21 |
| 2018-12-31 | 29.95 | $1.84 | 16.26 |
| 2018-09-30 | 35.76 | $1.58 | 22.59 |
| 2018-06-30 | 23.75 | $1.36 | 17.42 |
| 2018-03-31 | 18.54 | $1.20 | 15.49 |
| 2017-12-31 | 14.35 | $1.21 | 11.90 |
| 2017-09-30 | 12.23 | $1.10 | 11.07 |
| 2017-06-30 | 18.29 | $1.02 | 17.89 |
| 2017-03-31 | 21.18 | $0.80 | 26.32 |
| 2016-12-31 | 14.93 | $0.84 | 17.80 |
| 2016-09-30 | 21.92 | $0.77 | 28.29 |
| 2016-06-30 | 19.83 | $0.74 | 26.98 |
| 2016-03-31 | 16.98 | $0.69 | 24.50 |
| 2015-12-31 | 20.48 | $0.68 | 30.25 |
| 2015-09-30 | 21.47 | $0.59 | 36.11 |
| 2015-06-30 | 20.00 | $0.53 | 37.49 |
| 2015-03-31 | 15.59 | $0.48 | 32.56 |
| 2014-12-31 | 13.76 | $0.45 | 30.35 |
| 2014-09-30 | 10.00 | $0.38 | 26.57 |
| 2014-06-30 | 9.92 | $0.33 | 30.03 |
| 2014-03-31 | 10.34 | $0.30 | 34.38 |
| 2013-12-31 | 8.85 | $0.29 | 30.53 |
| 2013-09-30 | 7.06 | $0.26 | 27.08 |
| 2013-06-30 | 5.61 | $0.25 | 22.11 |
| 2013-03-31 | 4.18 | $0.26 | 16.06 |
| 2012-12-31 | 3.40 | $0.28 | 12.27 |
| 2012-09-30 | 3.76 | $0.29 | 12.97 |
| 2012-06-30 | 3.24 | $0.33 | 9.78 |
| 2012-03-31 | 2.61 | $0.36 | 7.18 |
| 2011-12-31 | 2.33 | $0.39 | 6.01 |
| 2011-09-30 | 3.00 | $0.42 | 7.16 |
| 2011-06-30 | 3.62 | $0.45 | 8.03 |
| 2011-03-31 | 3.88 | $0.21 | 18.14 |
| 2010-12-31 | 3.41 | $0.25 | 13.89 |
| 2010-09-30 | 3.31 | $0.15 | 22.02 |
| 2010-06-30 | 2.89 | $0.18 | 16.33 |
| 2010-03-31 | 2.44 | $0.20 | 11.97 |
| 2009-12-31 | 2.02 | $-0.10 | -20.15 |
| 2009-09-30 | 1.98 | $-0.05 | -40.13 |
| 2009-06-30 | 1.55 | $0.01 | 143.29 |
| 2009-03-31 | 1.04 | $0.08 | 12.62 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $27.549B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||